Selected research
Industry Research
C13 Stable Isotope Labeled Biomolecules Industry Research Report 2026
Market perspective
The global C13 Stable Isotope Labeled Biomolecules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for C13 Stable Isotope Labeled Biomolecules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for C13 Stable Isotope Labeled Biomolecules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for C13 Stable Isotope Labeled Biomolecules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of C13 Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Icon Isotopes, IsoLife BV, LGC Standards, Medical Isotopes, Omicron Biochemicals, Sigma-Aldrich, Toronto Research Chemicals and WITEGA Laboratorien, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global C13 Stable Isotope Labeled Biomolecules market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
C13 Stable Isotope Labeled Biomolecules Market by Company
Cambridge Isotope Laboratories
Icon Isotopes
IsoLife BV
LGC Standards
Medical Isotopes
Omicron Biochemicals
Sigma-Aldrich
Toronto Research Chemicals
WITEGA Laboratorien
Thermo Fisher Scientific
C13 Stable Isotope Labeled Biomolecules Segment by Type
Medical C13 Stable Isotope Labeled Biomolecules
Others
C13 Stable Isotope Labeled Biomolecules Segment by Application
Medical
Scientific Research
Industrial
Others
C13 Stable Isotope Labeled Biomolecules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C13 Stable Isotope Labeled Biomolecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of C13 Stable Isotope Labeled Biomolecules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C13 Stable Isotope Labeled Biomolecules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of C13 Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of C13 Stable Isotope Labeled Biomolecules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of C13 Stable Isotope Labeled Biomolecules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medical C13 Stable Isotope Labeled Biomolecules
- Others
Applications
- Medical
- Scientific Research
- Industrial
- Others
Companies covered
- Cambridge Isotope Laboratories
- Icon Isotopes
- IsoLife BV
- LGC Standards
- Medical Isotopes
- Omicron Biochemicals
- Sigma-Aldrich
- Toronto Research Chemicals
- WITEGA Laboratorien
- Thermo Fisher Scientific
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global C13 Stable Isotope Labeled Biomolecules Market Size (2021-2032)
- 2.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales (2021-2032)
- 2.2.3 Global C13 Stable Isotope Labeled Biomolecules Market Average Price (2021-2032)
- 2.3 C13 Stable Isotope Labeled Biomolecules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Medical C13 Stable Isotope Labeled Biomolecules
- 2.3.3 Others
- 2.4 C13 Stable Isotope Labeled Biomolecules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical
- 2.4.3 Scientific Research
- 2.4.4 Industrial
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global C13 Stable Isotope Labeled Biomolecules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global C13 Stable Isotope Labeled Biomolecules Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global C13 Stable Isotope Labeled Biomolecules Revenue of Manufacturers (2021-2026)
- 3.4 Global C13 Stable Isotope Labeled Biomolecules Average Price by Manufacturers (2021-2026)
- 3.5 Global C13 Stable Isotope Labeled Biomolecules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of C13 Stable Isotope Labeled Biomolecules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of C13 Stable Isotope Labeled Biomolecules, Product Type & Application
- 3.8 Global Manufacturers of C13 Stable Isotope Labeled Biomolecules, Established Date
- 3.9 Global C13 Stable Isotope Labeled Biomolecules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Cambridge Isotope Laboratories
- 4.1.1 Cambridge Isotope Laboratories Company Information
- 4.1.2 Cambridge Isotope Laboratories Business Overview
- 4.1.3 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.1.5 Cambridge Isotope Laboratories Recent Developments
- 4.2 Icon Isotopes
- 4.2.1 Icon Isotopes Company Information
- 4.2.2 Icon Isotopes Business Overview
- 4.2.3 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.2.5 Icon Isotopes Recent Developments
- 4.3 IsoLife BV
- 4.3.1 IsoLife BV Company Information
- 4.3.2 IsoLife BV Business Overview
- 4.3.3 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 IsoLife BV C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.3.5 IsoLife BV Recent Developments
- 4.4 LGC Standards
- 4.4.1 LGC Standards Company Information
- 4.4.2 LGC Standards Business Overview
- 4.4.3 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 LGC Standards C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.4.5 LGC Standards Recent Developments
- 4.5 Medical Isotopes
- 4.5.1 Medical Isotopes Company Information
- 4.5.2 Medical Isotopes Business Overview
- 4.5.3 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.5.5 Medical Isotopes Recent Developments
- 4.6 Omicron Biochemicals
- 4.6.1 Omicron Biochemicals Company Information
- 4.6.2 Omicron Biochemicals Business Overview
- 4.6.3 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.6.5 Omicron Biochemicals Recent Developments
- 4.7 Sigma-Aldrich
- 4.7.1 Sigma-Aldrich Company Information
- 4.7.2 Sigma-Aldrich Business Overview
- 4.7.3 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.7.5 Sigma-Aldrich Recent Developments
- 4.8 Toronto Research Chemicals
- 4.8.1 Toronto Research Chemicals Company Information
- 4.8.2 Toronto Research Chemicals Business Overview
- 4.8.3 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.8.5 Toronto Research Chemicals Recent Developments
- 4.9 WITEGA Laboratorien
- 4.9.1 WITEGA Laboratorien Company Information
- 4.9.2 WITEGA Laboratorien Business Overview
- 4.9.3 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.9.5 WITEGA Laboratorien Recent Developments
- 4.10 Thermo Fisher Scientific
- 4.10.1 Thermo Fisher Scientific Company Information
- 4.10.2 Thermo Fisher Scientific Business Overview
- 4.10.3 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Portfolio
- 4.10.5 Thermo Fisher Scientific Recent Developments
5 Global C13 Stable Isotope Labeled Biomolecules Market Scenario by Region
- 5.1 Global C13 Stable Isotope Labeled Biomolecules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021-2032
- 5.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021-2026
- 5.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2027-2032
- 5.3 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region: 2021-2032
- 5.3.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region: 2021-2026
- 5.3.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region: 2027-2032
- 5.4 North America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.4.1 North America C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.4.3 North America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.5.1 Europe C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.5.3 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.6.1 Asia Pacific C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific C13 Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.7.1 South America C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.7.3 South America C13 Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa C13 Stable Isotope Labeled Biomolecules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
- 6.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2032)
- 6.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
- 6.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2032)
- 6.3 Global C13 Stable Isotope Labeled Biomolecules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
- 7.1.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2032)
- 7.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
- 7.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2032)
- 7.3 Global C13 Stable Isotope Labeled Biomolecules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 C13 Stable Isotope Labeled Biomolecules Value Chain Analysis
- 8.1.1 C13 Stable Isotope Labeled Biomolecules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 C13 Stable Isotope Labeled Biomolecules Production Mode & Process
- 8.2 C13 Stable Isotope Labeled Biomolecules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 C13 Stable Isotope Labeled Biomolecules Distributors
- 8.2.3 C13 Stable Isotope Labeled Biomolecules Customers
9 Global C13 Stable Isotope Labeled Biomolecules Analyzing Market Dynamics
- 9.1 C13 Stable Isotope Labeled Biomolecules Industry Trends
- 9.2 C13 Stable Isotope Labeled Biomolecules Industry Drivers
- 9.3 C13 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges
- 9.4 C13 Stable Isotope Labeled Biomolecules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst